Sanofi, Facing Threat From Generics, Moves to Buy Hemophilia Drug Maker

By CHAD BRAY from NYT Business Day https://www.nytimes.com/2018/01/22/business/dealbook/sanofi-hemophilia-bioverativ.html?partner=IFTTT